Sitafloxacin

Sitafloxacin
Clinical data
Routes of
administration
Oral
ATC code J01MA21 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 127254-12-0 N
PubChem (CID) 461399
ChemSpider 405945 YesY
UNII 3GJC60U4Q8 N
ChEMBL CHEMBL108821 YesY
Chemical and physical data
Formula C19H18ClF2N3O3
Molar mass 409.81
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.

See also

References

  1. Anderson, DL. (Jul 2008). "Sitafloxacin hydrate for bacterial infections.". Drugs Today (Barc). 44 (7): 489–501. doi:10.1358/dot.2008.44.7.1219561. PMID 18806900.

Further reading

This article is issued from Wikipedia - version of the 5/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.